Boston Scientific Corporation (0HOY.L)
USD 105.22
(1.9%)
USD 105.22
(1.9%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.59 Billion USD | 128.08% |
| 2022 | 698 Million USD | -32.88% |
| 2021 | 1.04 Billion USD | 1368.29% |
| 2020 | -82 Million USD | -101.74% |
| 2019 | 4.7 Billion USD | 181.27% |
| 2018 | 1.67 Billion USD | 1506.73% |
| 2017 | 104 Million USD | -70.03% |
| 2016 | 347 Million USD | 245.19% |
| 2015 | -239 Million USD | -100.84% |
| 2014 | -119 Million USD | 1.65% |
| 2013 | -121 Million USD | 97.03% |
| 2012 | -4.06 Billion USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 494 Million USD | -1.98% |
| 2024 Q2 | 324 Million USD | -34.41% |
| 2024 Q3 | 468 Million USD | 44.44% |
| 2023 Q3 | 504 Million USD | 86.67% |
| 2023 Q4 | 504 Million USD | 0.0% |
| 2023 Q1 | 314 Million USD | 124.29% |
| 2023 Q2 | 270 Million USD | -14.01% |
| 2023 FY | 1.59 Billion USD | 128.22% |
| 2022 Q4 | 140 Million USD | -25.53% |
| 2022 Q2 | 260 Million USD | 134.23% |
| 2022 Q1 | 111 Million USD | 18.09% |
| 2022 FY | 698 Million USD | -32.88% |
| 2022 Q3 | 188 Million USD | -27.69% |
| 2021 Q3 | 419 Million USD | 125.27% |
| 2021 FY | 1.04 Billion USD | 1368.29% |
| 2021 Q1 | 327 Million USD | 66.84% |
| 2021 Q2 | 186 Million USD | -43.12% |
| 2021 Q4 | 94 Million USD | -77.57% |
| 2020 Q3 | -169 Million USD | -11.18% |
| 2020 Q4 | 196 Million USD | 215.98% |
| 2020 FY | -82 Million USD | -101.74% |
| 2020 Q1 | 11 Million USD | -99.72% |
| 2020 Q2 | -152 Million USD | -1481.82% |
| 2019 Q3 | 126 Million USD | -18.18% |
| 2019 Q2 | 154 Million USD | -63.68% |
| 2019 FY | 4.7 Billion USD | 181.27% |
| 2019 Q1 | 424 Million USD | 9.84% |
| 2019 Q4 | 3.99 Billion USD | 3071.43% |
| 2018 Q3 | 432 Million USD | -22.16% |
| 2018 Q1 | 298 Million USD | 148.46% |
| 2018 Q2 | 555 Million USD | 86.24% |
| 2018 Q4 | 386 Million USD | -10.65% |
| 2018 FY | 1.67 Billion USD | 1506.73% |
| 2017 Q1 | 290 Million USD | 133.87% |
| 2017 FY | 104 Million USD | -70.03% |
| 2017 Q4 | -615 Million USD | -317.31% |
| 2017 Q3 | 283 Million USD | 93.84% |
| 2017 Q2 | 146 Million USD | -49.66% |
| 2016 FY | 347 Million USD | 245.19% |
| 2016 Q1 | 202 Million USD | 242.25% |
| 2016 Q2 | -207 Million USD | -202.48% |
| 2016 Q3 | 228 Million USD | 210.14% |
| 2016 Q4 | 124 Million USD | -45.61% |
| 2015 Q4 | -142 Million USD | 28.28% |
| 2015 Q3 | -198 Million USD | -294.12% |
| 2015 FY | -239 Million USD | -100.84% |
| 2015 Q2 | 102 Million USD | 10300.0% |
| 2015 Q1 | -1 Million USD | 99.67% |
| 2014 FY | -119 Million USD | 1.65% |
| 2014 Q2 | 4 Million USD | -96.99% |
| 2014 Q4 | -299 Million USD | -795.35% |
| 2014 Q3 | 43 Million USD | 975.0% |
| 2014 Q1 | 133 Million USD | 23.15% |
| 2013 Q1 | -354 Million USD | -680.33% |
| 2013 Q3 | -5 Million USD | -103.85% |
| 2013 Q4 | 108 Million USD | 2260.0% |
| 2013 FY | -121 Million USD | 97.03% |
| 2013 Q2 | 130 Million USD | 136.72% |
| 2012 Q4 | 61 Million USD | 0.0% |
| 2012 FY | -4.06 Billion USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 1263.751% |
| Accuray Incorporated | -15.54 Million USD | 10347.668% |
| Align Technology, Inc. | 445.05 Million USD | -257.935% |
| Elevance Health Inc. | 5.98 Billion USD | 73.392% |
| AxoGen, Inc. | -21.71 Million USD | 7435.605% |
| CVS Health Corporation | 8.34 Billion USD | 80.908% |
| Cardinal Health, Inc. | 852 Million USD | -86.972% |
| Centene Corporation | 2.7 Billion USD | 41.044% |
| DaVita Inc. | 691.53 Million USD | -130.357% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 69.611% |
| Hologic, Inc. | 789.5 Million USD | -101.773% |
| Humana Inc. | 2.48 Billion USD | 35.998% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -88.511% |
| Laboratory Corporation of America Holdings | 418 Million USD | -281.1% |
| Masimo Corporation | 81.5 Million USD | -1854.601% |
| McKesson Corporation | 3 Billion USD | 46.935% |
| Patterson Companies, Inc. | 185.93 Million USD | -756.769% |
| Quest Diagnostics Incorporated | 854 Million USD | -86.534% |
| ResMed Inc. | 1.02 Billion USD | -56.031% |
| Henry Schein, Inc. | 416 Million USD | -282.933% |
| Teladoc Health, Inc. | -220.36 Million USD | 822.882% |
| Universal Health Services, Inc. | 717.79 Million USD | -121.93% |
| Veeva Systems Inc. | 525.7 Million USD | -203.022% |
| Baxter International Inc. | 2.65 Billion USD | 40.023% |
| Becton, Dickinson and Company | 1.48 Billion USD | -7.345% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 11.402% |
| Danaher Corporation | 4.2 Billion USD | 62.071% |
| Stryker Corporation | 3.16 Billion USD | 49.668% |
| Medtronic plc | 3.67 Billion USD | 56.665% |